Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:1025 TB drug resistance detection by PCR
Search Links: General Info : Protocols : Patient Info

Description Drug resistance in M.tuberculosis is frequently associated with mutations in specific genes. PCR amplification of these regions and subsequent detection of mutations using a line probe assay provides a method of predicting resistance which is more rapid than phenotypic methods. Tests are available for the detection of markers of resistance to rifampicin and isoniazid using the GenoType MTBDRplus assay (Hain Life Science) and for second line agents fluoroquinolones, aminoglycosides and cyclic peptides using the GenoType MTBDRsl assay (Hain LifeScience).
Indication These assays are available following discussion with a Microbiology Consultant or Specialist Clinical Scientist. They are useful for the rapid prediction of drug resistance in samples from patients with risk factors associated with drug resistance (e.g. contact with a known case of MDR-TB, born/previously resident of a country with high prevalence of MDR-TB, previously treated for tuberculosis). They may also be appropriate in cases where co-morbidities may complicate the choice of suitable anti-tuberculous drugs.
Additional Info Specimens will require a positive M.tuberculosis complex PCR before testing to ensure sufficient DNA available for successful testing.
Concurrent TestsMycobacterium TB PCR
Dietary Requirementsna

Interpretation A negative result does not rule out drug resistance because not all mechanisms for resistance for the different drugs are known. Approximately 95% of rifampicin resistant strains and 80% of isoniazid resistant strains are detected by the MTBDRplus assay. Approximately 60-80% resistant strains for second line agents are detected by the MTBDRsl assay. All genotypic results should be confirmed by phenotypic testing following mycobacterial culture.

Ref. Range (Male)
Ref. Range (Female)
Ref. Range (Paed)
Ref. Range Notes
Units - Not Defined -

Other Help:National Laboratory Medicine Handbook

IP Acute TAT14 days
IP Routine TAT14 days
GP Acute TAT14 days
GP Routine TAT14 days
Turnround CommentNA
Originally edited by : na. Last edited on 17/07/2018 10:10:58. Published By on 17/07/2017 10:10:58.